Interaction between tumour necrosis factor α ribozyme and cellular proteins: Involvement in ribozyme stability and activity

Journal of Molecular Biology

Volumn 242, Issue 5, 1994, Pages 619-629

  Sioud, Mouldy ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Proteins; Ribozyme; Stability; TNF

Indexed keywords

RIBOZYME; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HL 60; COMPLEX FORMATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STABILITY; RNA METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0028153167     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1994.1612     Document Type: Article

References (22)

1. Ahsen, U. & Schroeder, R. (1993). RXA as a catalyst: natural and designed ribozymes. Bio Essays, 15, 299-307.
2. Cameron, F. & Jennings, P (1989). Specific gene suppression by engineered ribozymes in monkey cells. Proc. Nat. Acad. Sci, U.S.A. 86, 9139-9143.
3. Cech, T. (1987). The chemistry of self-spbeing RNA and RNA enzymes. Science, 236, 1532-1539.
4. Chomczynski, P & Saechi, N. (1987). Single step method of RXA isolation by acid guanidinium thioeyanate phenol chloroform extraction. Anal. Biochem. 162, 156-159.
5. Cotton, M. & Birnstiel, M. L. (1989). Ribozyme mediated destruction of RNA in vivo. EMBO J 8, 3861-3866.
6. Forster, A. & Symons, R. (1987). Self-cleavage of plus and minus RNAs of a vi ruso id and a structural model for the active sites. Cell, 49, 211-220.
7. Fujita, T., Takaoka, C. Matsui, H. & Taniguchí, T. (1983). Structure of the human interleukin 2 gene. Proc. Nat. Acad. Sei., U.S.A. 80, 7437-7441.
8. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N. & Altman, S. (1983). The RNA moiety of ribonuelease P is the catalytic“subunit of the enzyme, Cell, 35, 849-847.
9. Haseloff, J. & Gerlaeh W. L. (1988). Simple RNA enzymes with new and highly specific etido ribo nuclease activities. Nature (London), 334, 585-591.
10. Kroemer, G. & Martinez-A, C. (1991). Cytokines and autoimmune disease. Clin. Immunol. Immunopath. 61. 275-295.
11. Lacmmli, U. K. (1970). Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (London), 227, 680-682.
12. Li, Y., Guerrier-Takada, C. & Altman, S. (1992). Target cleavage of m RNA in vitro bv RNase P from E. coli. Proc. Nat. Acad. Set., U.S.A. 89, 3185-3189.
13. Paolella G., Sproat, B. S. & Lamond, A. I. (1992). Nuclease resistant ribozvmes with catalytic activity. EMBO J. 11, 1913-1919.
14. Saenger, W. (1988). In Principles of Nucleic Acid Structure (Cantor, C. R., ed.), Springer Verlag, New York, Berlin, Heidelberg, Tokyo.
15. Sarver, N., Cantin, E. M., Chang, P S., Zaia, J. A., Ladne, P A., Stephens, D. A. & Rossi, J. J. (1990). Ribozymes as potential anti-HIV-1 therapeutic agents. Science, 247, 1222-1225.
16. Sioud, M. & Drliea, K. (1991). Prevention of HIV-l integrase expression in E. coli by a ribozymes. Proc. Nat. Acad. Sei., U.S.A. 88, 7303-7307.
17. Sioud, M., Natvig, J. B. & Førre Ø. (1992). Preformed ribozyme destroys tumour necrosis factor m RNA in human cells. J, Mol. Biol. 223, 831-835.
18. Stevens, A. (1988). m RNA-decapping enzyme from Saccharomyces cerevisiae: purification and unique substrate specificity for long RNA chains. Mol. Cell. Biol. 8, 2005-2010.
19. Sullivan, S. M. (1993). Lipsome-mediated uptake of ribozvmes. Methods: Companion Methods Enzymol. 5, 61-66.
20. Tinoco, I. R., Puglisi, I. D. & Wyatt, I. R. (1990). In RNA Folding in Nuclear Acids and Molecular Biology. (Eckstein. E & Lilley, D., eds), vol. 4, 205-226, Springer Verlag, New York, Berlin, Heidelberg, Tokyo.
21. Tsuehihashi, Z., Khosla, M. & Hersehlag, D. (1993). Protein enhancement of hammerhead ribozyme catalysis. Science, 262, 99-102.
22. Woolf, T. M., Jennings, C. G. B., Rebagliati, M. & Melton, D. A. (1990). The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxy nucleotides in Xenopus oocytes and embryos. Nucl. Acids Res. 18, 1763-1769.